title: High Vitamin C Intake with High Serum β-Cryptoxanthin Associated with Lower Risk for Osteoporosis in Post-Menopausal Japanese Female Subjects: Mikkabi Cohort Study.
abstract: Recent epidemiological studies show that antioxidant vitamins and carotenoids might be beneficial to the maintenance of bone health. Recently, we found that serum carotenoids were inversely associated with the risk of developing osteoporosis in post-menopausal Japanese female subjects. However, little is known about the vitamin alone and/or the combination of the vitamin and carotenoid with the risk of osteoporosis. The objective of this study was to investigate longitudinally whether antioxidant vitamins and their combination with carotenoids are associated with the risk of developing of osteoporosis. We conducted a follow-up study on 187 post-menopausal female subjects from the Mikkabi prospective cohort study. Those who participated in previous bone mineral density (BMD) surveys and completed four years of follow-up were examined longitudinally. During a four-year follow-up, fifteen of the post-menopausal female subjects developed new-onset osteoporosis. After adjustment for confounders, the odds ratios (OR) for osteoporosis in the highest tertiles of vitamins C and E and retinol intakes against the lowest tertiles were 0.15 (95% confidence interval (CI): 0.02-0.99), 0.50 (CI: 0.08-3.23), and 1.49 (CI: 0.36-6.22), respectively. Furthermore, a significantly lower odds ratio was observed in the higher vitamin C intake group (169-625 mg/d) with higher serum β-cryptoxanthin (1.88-10.53 μM) against the lower vitamin C intake group (47-168 mg/d) with lower serum β-cryptoxanthin (0.24-1.84 μM) used for the reference group (p<0.05). The combination of β-cryptoxanthin and vitamin C is inversely associated with the risk of developing osteoporosis in post-menopausal Japanese female subjects.
authors.affiliation: Citrus Research Division, NARO Institute of Fruit Tree Science, National Agriculture and Food Research Organization (NARO).
authors.forename: Minoru
authors.initials: M
authors.lastname: Sugiura
authors.forename: Mieko
authors.initials: M
authors.lastname: Nakamura
authors.forename: Kazunori
authors.initials: K
authors.lastname: Ogawa
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Ikoma
authors.forename: Masamichi
authors.initials: M
authors.lastname: Yano
mesh_terms: D000368:Aged; D001205:Ascorbic Acid / Q000008:administration & dosage*; D000072743:Beta-Cryptoxanthin / Q000097:blood*; D015519:Bone Density; D015331:Cohort Studies; D004032:Diet; D005260:Female; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008875:Middle Aged; D016017:Odds Ratio; D015663:Osteoporosis, Postmenopausal / Q000097:blood* / Q000453:epidemiology; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D000072743:Beta-Cryptoxanthin; D001205:Ascorbic Acid